Abstract
Diabetes mellitus is a complex metabolic disorder and is considered a fast-growing global health problem. Type 2 diabetes (T2D) represents the majority of total diabetes prevalence and β-cell dysfunction has been described as a crucial point for this disease development and progression. To date, all of the common anti-hyperglycaemic drugs used for diabetes management cause undesirable side effects or problems with long-term efficacy or safety and the development of alternative approaches for the prevention as well as for the treatment of T2D might be a valuable solution to meet this rising demand. In this regards, numerous epidemiological studies indicate that exposure to certain polyphenol compounds is associated with the prevention of chronic diseases, including diabetes. Here, we review growing evidence suggesting that polyphenols can modulate the activity of various molecular targets, which are known to control β-cell function, involved in the development and the progression of this diabetes. The protective effects of polyphenols on β-cell function is reported with a particular focus on the mechanism of action behind polyphenol putative bioactivity. Animal and in vitro studies selected in this review, reporting about both flavonoid and non-flavonoid compounds, highlight the direct action of polyphenols on pancreatic β-cells, stimulating insulin secretion through the activation of specific cellular targets and protecting these cells from damages mediated by oxidative stress and inflammation, both typically elevated in diabetes. Some of the reviewed studies describe polyphenol effects comparable to those exerted by many drugs commonly used in diabetes treatment, and, in some occasions, synergistic polyphenol-drug interactions. Finally, future studies need to be addressed to the effects of specific polyphenol human and microbial metabolites, which are still poorly studied, in order to better define the preventive and therapeutic approach to contrast β-cell failure and diabetes progression.
Similar content being viewed by others
References
Adewole SO, Caxton-Martins EA, Ojewole JA (2006) Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med 4:64–74
Adisakwattana S, Moonsan P, Yibchok-Anun S (2008) Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 56:7838–7844
Ae Park S, Choi MS, Cho SY et al (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci 79:1207–1213
Al-Numair KS, Chandramohan G, Veeramani C et al (2014) Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. Redox Rep. doi:10.1179/1351000214Y.0000000117
Annadurai T, Muralidharan AR, Joseph T et al (2012) Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats. J Physiol Biochem 68:307–318
Annadurai T, Thomas PA, Geraldine P (2013) Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced experimental diabetes mellitus. Free Radic Res 47:793–803
Aron PM, Kennedy JA (2008) Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res 52:79–104
Ashcroft FM, Rorsman P (2004) Molecular defects in insulin secretion in type-2 diabetes. Rev Endocr Metab Disord 5:135–142
Babu PV, Liu D, Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 24:1777–1789
Bahadoran Z, Mirmiran P, Azizi F (2013) Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 12:43
Bardy G, Virsolvy A, Quignard JF et al (2013) Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol 169:1102–1113
Behloul N, Wu G (2013) Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 698:31–38
Bensellam M, Laybutt DR, Jonas JC (2012) The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol 364:1–27
Bhakkiyalakshmi E, Shalini D, Sekar TV et al (2014) Therapeutic potential of pterostilbene against pancreatic beta-cell apoptosis mediated through Nrf2. Br J Pharmacol 171:1747–1757
Bhattacharya S, Oksbjerg N, Young JF et al (2014) Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes Metab 16:602–612
Bonora E (2008) Protection of pancreatic beta-cells: is it feasible? Nutr Metab Cardiovasc Dis 18:74–83
Briaud I, Lingohr MK, Dickson LM et al (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52:974–983
Brunzell JD, Robertson RP, Lerner RL et al (1976) Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42:222–229
Cai EP, Lin JK (2009) Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem 57:9817–9827
Cao Y, Bao S, Yang W et al (2014) Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr Res 34:1066–1074
Chaturvedi N (2007) The burden of diabetes and its complications: trends and implications for intervention. Diabetes Res Clin Pract 76(Suppl 1):S3–12
Chen WP, Chi TC, Chuang LM et al (2007) Resveratrol enhances insulin secretion by blocking K(ATP) and K(V) channels of beta cells. Eur J Pharmacol 568:269–277
Chiasson JL, Josse RG, Gomis R et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–2077
Cho JM, Chang SY, Kim DB et al (2012) Effects of physiological quercetin metabolites on interleukin-1beta-induced inducible NOS expression. J Nutr Biochem 23:1394–1402
Choi MS, Jung UJ, Yeo J et al (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24:74–81
Clifford MN (2000) Anthocyanins—nature, occurrence and dietary burden. J Sci Food Agric 80:1063–1072
Coskun O, Kanter M, Korkmaz A et al (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51:117–123
Costes S, Broca C, Bertrand G et al (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55:2220–2230
Coward L, Smith M, Kirk M et al (1998) Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 68:1486S–1491S
Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Natural Product Reports 26:1001–1043
Crozier A, Del Rio D, Clifford MN (2010) Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31:446–467
Dai X, Ding Y, Zhang Z et al (2013) Quercetin and quercitrin protect against cytokineinduced injuries in RINm5F beta-cells via the mitochondrial pathway and NF-kappaB signaling. Int J Mol Med 31:265–271
Dalle S, Burcelin R, Gourdy P (2013) Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic beta-cell impairments in type 2 diabetes. Cell Signal 25:570–579
Day AJ, Canada FJ, Diaz JC et al (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468:166–170
Del Prato S, Tiengo A (2001) The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 17:164–174
Del Rio D, Costa LG, Lean ME et al (2010) Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis 20:1–6
Del Rio D, Rodriguez-Mateos A, Spencer JP et al (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18:1818–1892
Do GM, Jung UJ, Park HJ et al (2012) Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res 56:1282–1291
Donovan JL, Manach C, Faulks RM et al (2006) Absorption and metabolism of dietary plant secondary metabolites. In: Crozier A, Clifford MN, Ashinara H (eds) Plant secondary metabolites: occurrence, structure and role in the human diet. Blackwell Publishing, Oxford, pp 303–351
Drews G, Krippeit-Drews P, Dufer M (2010) Oxidative stress and beta-cell dysfunction. Pflugers Arch 460:703–718
Elmarakby AA, Ibrahim AS, Faulkner J et al (2011) Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascul Pharmacol 55:149–156
Fernandez-Millan E, Ramos S, Alvarez C et al (2014) Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways. Food Chem Toxicol 66:245–253
Forouhi NG, Wareham NJ (2010) Epidemiology of diabetes. Medicine 38:602–606
Frodin M, Sekine N, Roche E et al (1995) Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem 270:7882–7889
Fu Z, Zhang W, Zhen W et al (2010) Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology 151:3026–3037
Fu Z, Zhen W, Yuskavage J et al (2011) Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br J Nutr 105:1218–1225
Fu Z, Gilbert ER, Pfeiffer L et al (2012) Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Appl Physiol Nutr Metab 37:480–488
Fu Z, Yuskavage J, Liu D (2013) Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice. J Agric Food Chem 61:4303–4309
Gee JM, DuPont MS, Day AJ et al (2000) Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr 130:2765–2771
Gharib A, Faezizadeh Z, Godarzee M (2013) Treatment of diabetes in the mouse model by delphinidin and cyanidin hydrochloride in free and liposomal forms. Planta Med 79:1599–1604
Gilbert ER, Liu D (2013) Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic beta-cell function. Food Funct 4:200–212
Gu L, Kelm MA, Hammerstone JF et al (2004) Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134:613–617
Habtemariam S, Varghese GK (2014) The antidiabetic therapeutic potential of dietary polyphenols. Curr Pharm Biotechnol 15:391–400
Han MK (2003) Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp Mol Med 35:136–139
Hanhineva K, Torronen R, Bondia-Pons I et al (2010) Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 11:1365–1402
Hartley L, Igbinedion E, Holmes J et al. (2013) Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases. Cochrane Database Syst Rev 6:CD009874
Hirota S, Nishioka T, Shimoda T et al (2001) Quercetin glucosides are hydrolyzed to quercetin in human oral cavity to participate in peroxidase-dependent scavenging of hydrogen peroxide. Food Sci Technol Res 7:239–245
Ishisaka A, Kawabata K, Miki S et al (2013) Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS ONE 8:e80843
Jayaprakasam B, Vareed SK, Olson LK et al (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 53:28–31
Jeong SM, Kang MJ, Choi HN et al (2012) Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract 6:201–207
Jung UJ, Lee MK, Park YB et al (2006) Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther 318:476–483
Kaneko YK, Takii M, Kojima Y et al (2015) Structure-dependent inhibitory effects of green tea catechins on insulin secretion from pancreatic beta-cells. Biol Pharm Bull 38:476–481
Kawai Y, Nishikawa T, Shiba Y et al (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283:9424–9434
Kim EK, Kwon KB, Song MY et al (2007a) Flavonoids protect against cytokine-induced pancreatic β-cell damage through suppression of nuclear factor κB activation. Pancreas 35:e1–e9
Kim EK, Kwon KB, Song MY et al (2007b) Genistein protects pancreatic beta cells against cytokine-mediated toxicity. Mol Cell Endocrinol 278:18–28
Kim MK, Jung HS, Yoon CS et al (2010) EGCG and quercetin protected INS-1 cells in oxidative stress via different mechanisms. Front Biosci (Elite Ed) 2:810–817
Kim JH, Kang MJ, Choi HN et al (2011) Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 5:107–111
Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Knowler WC, Hamman RF, Edelstein SL et al (2005) Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 54:1150–1156
Knutson KL, Hoenig M (1994) Identification and subcellular characterization of protein kinase-C isoforms in insulinoma beta-cells and whole islets. Endocrinology 135:881–886
Kobori M, Masumoto S, Akimoto Y, Takahashi Y (2009) Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 53:859–868
Ku CR, Lee HJ, Kim SK et al (2012) Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic beta-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr J 59:103–109
Landete JM (2011) Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health. Food Res Int 44:1150–1160
Lee JS (2006) Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci 79:1578–1584
Lee MJ, Lambert JD, Prabhu S et al (2004) Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomark Prev 13:132–137
Lee JH, Song MY, Song EK et al (2009a) Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 58:344–351
Lee SJ, Kim HE, Choi SE et al (2009b) Involvement of Ca2+/calmodulin kinase II (CaMK II) in genistein-induced potentiation of leucine/glutamine-stimulated insulin secretion. Mol Cells 28:167–174
Lee YE, Kim JW, Lee EM et al (2012) Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice. PLoS ONE 7:e50412
Li JM, Wang W, Fan CY et al (2013) Quercetin preserves beta-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid Based Complement Alternat Med 2013:303902
Lin CY, Ni CC, Yin MC et al (2012) Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine 59:65–71
Lindstrom J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679
Liu D, Zhen W, Yang Z et al (2006) Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes 55:1043–1050
Longuet C, Broca C, Costes S et al (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 146:643–654
Mahmoud AM, Ashour MB, Abdel-Moneim A et al (2012) Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 26:483–490
Manach C, Williamson G, Morand C et al (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242S
Marchetti P, Dotta F, Lauro D et al (2008) An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 146:4–11
Martin MA, Fernandez-Millan E, Ramos S et al (2014) Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol Nutr Food Res 58:447–456
Mears D (2004) Regulation of insulin secretion in islets of Langerhans by Ca(2+)channels. J Membr Biol 200:57–66
Mena P, Garcia-Viguera C, Navarro-Rico J et al (2011) Phytochemical characterisation for industrial use of pomegranate (Punica granatum L.) cultivars grown in Spain. J Sci Food Agric 91:1893–1906
Neveu V, Perez-Jimenez J, Vos F et al (2010) Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database 2010:bap024
Ock KC, Sang JC, Song WO (2007) Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 137:1244–1252
Palsamy P, Subramanian S (2010) Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 224:423–432
Panda S, Kar A (2007) Apigenin (4′,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J Pharm Pharmacol 59:1543–1548
Pinent M, Castell A, Baiges I et al (2008) Bioactivity of flavonoids on insulin-secreting cells. Compr Rev Food Sci Food Saf 7:299–308
Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366
Prabhakar PK, Prasad R, Ali S, et al (2013) Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Phytomedicine 20:488–494
Prasath GS, Sundaram CS, Subramanian SP (2013) Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats. Endocrine 44:359–368
Punithavathi VR, Prince PS, Kumar R et al (2011) Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur J Pharmacol 650:465–471
Rahier J, Guiot Y, Goebbels RM et al (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32–42
Ramar M, Manikandan B, Raman T et al (2012) Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice. Eur J Pharmacol 690:226–235
Rauter AP, Martins A, Borges C et al (2010) Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res 24:S133–S138
Rodriguez-Mateos A, Vauzour D, Krueger CG et al (2014) Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update. Arch Toxicol 88:1803–1853
Rouse M, Younès A, Egan JM (2014) Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity. J Endocrinol 223:107–117
Roy M, Sen S, Chakraborti AS (2008) Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification. Life Sci 82:1102–1110
Roy S, Metya SK, Sannigrahi S et al (2013) Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell. Endocrine 44:369–379
Sala R, Mena P, Savi M et al (2015) Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. J Funct Foods 15:97–105
Sameermahmood Z, Raji L, Saravanan T et al (2010) Gallic acid protects RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions. Phytother Res 24(Suppl 1):S83–94
Sartor G, Schersten B, Carlstrom S et al (1980) Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29:41–49
Scalbert A, Manach C, Morand C et al (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287–306
Scully T (2012) Diabetes in numbers. Nature 485:S2–S3
Selma MV, Espin JC, Tomas-Barberan FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57:6485–6501
Sharma AK, Bharti S, Ojha S et al (2011) Up-regulation of PPARγ, heat shock protein-27 and-72 by naringin attenuates insulin resistance, β-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes. Br J Nutr 106:1713–1723
Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
Song EK, Hur H, Han MK (2003) Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res 26:559–563
Sorenson RL, Brelje TC, Roth C (1994) Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134:1975–1978
Suh KS, Chon S, Oh S et al (2010) Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biol Toxicol 26:189–199
Suh KS, Oh S, Woo JT et al (2012) Apigenin attenuates 2-deoxy-D-ribose-induced oxidative cell damage in HIT-T15 pancreatic β-cells. Biol Pharm Bull 35:121–126
Szkudelski T (2006) Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol 552:176–181
Szkudelski T (2008) The insulin-suppressive effect of resveratrol—an in vitro and in vivo phenomenon. Life Sci 82:430–435
Szkudelski T, Szkudelska K (2015) Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta 1852:1145-1154
Tuomilehto J, Lindstrom J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135C:357–364
Vetterli L, Brun T, Giovannoni L et al (2011) Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E β-cells and human islets through a SIRT1-dependent mechanism. J Biol Chem 286:6049–6060
Walle T, Browning AM, Steed LL et al (2005) Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 135:48–52
Wang X, Ouyang Y, Liu J et al (2014) Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349:g4490
Wenham RM, Landt M, Easom RA (1994) Glucose activates the multifunctional Ca2+/calmodulin-dependent protein kinase II in isolated rat pancreatic islets. J Biol Chem 269:4947–4952
Whalen K, Miller S, Onge ES (2015) The role of sodium-glucose co-transporter 2 inhibitors in the treatment of Type 2 diabetes. Clin Ther 37:1150-1166
Whiting DR, Guariguata L, Weil C et al (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311–321
Williamson G (2013) Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res 57:48–57
Wollheim CB, Sharp GW (1981) Regulation of insulin release by calcium. Physiol Rev 61:914–973
Wu X, Beecher GR, Holden JM et al (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54:4069–4075
Youl E, Bardy G, Magous R et al (2010) Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 161:799–814
Youl E, Magous R, Cros G et al (2014) MAP Kinase cross talks in oxidative stress-induced impairment of insulin secretion. Involvement in the protective activity of quercetin. Fundam Clin Pharmacol 28:608–615
Yun SY, Kim SP, Song DK (2006) Effects of (-)-epigallocatechin-3-gallate on pancreatic beta-cell damage in streptozotocin-induced diabetic rats. Eur J Pharmacol 541:115–121
Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM et al (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 100:188–196
Zanotti I, Dall’Asta M, Mena P et al (2015) Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct 6:13–31
Zhang Y, Liu D (2011) Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol 670:325–332
Zhang Z, Ding Y, Dai X et al (2011) Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur J Pharmacol 670:311–316
Zhang J, Chen L, Zheng J et al (2012) The protective effect of resveratrol on islet insulin secretion and morphology in mice on a high-fat diet. Diabetes Res Clin Pract 97:474–482
Zhang Y, Zhen W, Maechler P et al (2013) Small molecule kaempferol modulates PDX-1 protein expression and subsequently promotes pancreatic beta-cell survival and function via CREB. J Nutr Biochem 24:638–646
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dall’Asta, M., Bayle, M., Neasta, J. et al. Protection of pancreatic β-cell function by dietary polyphenols. Phytochem Rev 14, 933–959 (2015). https://doi.org/10.1007/s11101-015-9429-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11101-015-9429-x